To include your compound in the COVID-19 Resource Center, submit it here.

June 3 Company Quick Takes: EU pharmas form consortium to predict late-stage success; plus Lilly/Atomwise, Gilead/HitGen, Emergent and more

EU public-private consortium aims to better predict late-stage compounds
A group of pharmaceutical, technology and academic institutions formed a consortium to use machine learning on chemical libraries of 10 pharmaceutical companies to develop a platform that can more accurately predict

Read the full 392 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers